As an investor I've always been interested in, Prince Alwaleed carries an interesting story. His Citigroup investment has been well documented, first as a wild success, and then, well we all know what happened to Citigroup in 2008. I read his biography and reviewed it awhile back (a href="http://briskycapital.blogspot.com/2007/11/book-review-alwaleed-by-riz-khan.html"Click here to read review and purchase book/a).br /br /Today, I found a a href="http://www.bloomberg.com/apps/news?pid=20601087amp;sid=aGiKNISJrIkc"piece from Bloomberg /agiving us an update on how he has survived the recession. So far, it looks like he's done well:br /br /br /blockquotepAug. 29 (Bloomberg) -- Prince Alwaleed bin Talal, Citigroup Inc.’s largestbr /individual investor, was ranked the richest Saudi national by Arabian Business,br /even after losing 4.6 percent of his personal wealth in the past year.br /br /Alwaleed’s assets are valued at $16.3 billion, compared with $17.1 billionbr /last year, the Dubai-based magazine said today in its 2009 Saudi Rich List,br /citing the accounts of ...

The board of directors of Citigroup Inc. (C) will meet today to look at beleaguered banking giant’s options after its shares hit a 15-year low, and speculation is escalating that it will have to look at a break-up, spin-off or sale of at least part of the bank.

Citi’s shares have plunged 50% this week – including 26.4% yesterday, when they dropped $1.69 each to close at $4.71. It’s the first time since 1994 that the shares closed below $5.

Citigroup, once the biggest U.S. bank with a stock-market value of $274 billion at the end of 2006, dropped yesterday to about $26 billion, slipping to the last spot after Minneapolis-based U.S. Bancorp (USB) in a list of the Top 5 U.S. banks as measured by market value. Neither a plan by Chief Executive Officer Vikram S. Pandit announced this week to cut costs by

...

Yesterday we had no idea why NuVasive (NUVA) was being pummeled and threw out a guess that it had to do with the DOJ investigation into Medtronic's spine product, Infuse. Yesterday Medtronic (MDT) had a disappointing report but they only compete in the spine area - there is a news report that the feds are investigating off label use of a Medtronic spinal implant - I don't know about this product in relation to NuVasive's product line to know if this is the cause... I'd be curious to hear the analyst community's take on this one. So this could be guilt by association or in this market, a hedge fund liquidating but we've seen NuVasive drop off a cliff the ...

Last December, CITI (C) CEO Charles Prince admitted his frustration with the lack of movement in the bank’s share price and defended his strategy of organic growth and targeted international acquisitions. Public dissatisfaction from shareholders including the bank’s largest investor, Saudi Arabia’s Prince Alwaleed bin Talal, to improve the bank’s performance had many speculating Prince would soon be “free to pursue other opportunities”.

In July, Citi created unit to search the market for potential targets after striking several deals in Europe and elsewhere in recent months to reduce its dependence on the US consumer business.